Publications by authors named "Nicholas S Hellmann"

Claim this Profile
H
HIV-1 pol replication capacity predicts disease progression.
Eric S Daar, Karen L Kesler, Terri Wrin, Christos J Petropoulo, Michael Bates, Nicholas S Hellmann

AIDS· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, prospective study of phenotype susceptibility testing versus standard of care to manage antiretroviral therapy: CCTG 575.
Richard H Haubrich, Carol A Kemper, Nicholas S Hellmann, Philip H Keiser, Mallory D Witt

AIDS· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal assessment of immune response and viral characteristics in HIV-infected patients with prolonged CD4(+)/viral load discordance.
Susan S Kaplan, Guido Ferrari, Terri Wrin, Nicholas S Hellmann, Georgia D Tomaras

AIDS Res Hum Retroviruses· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the G190A substitution of HIV reverse transcriptase on phenotypic susceptibility of patient isolates to delavirdine.
Erik J Uhlmann, Pablo Tebas, Gregory A Storch, William G Powderly, Yolanda S Lie, Nicholas S Hellmann

J Clin Virol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 drug resistance in subjects with advanced HIV-1 infection in whom antiretroviral combination therapy is failing: a substudy of AIDS Clinical Trials Group Protocol 388.
Lisa M Demeter, Heather J Ribaudo, Alejo Erice, Susan H Eshleman, Scott M Hammer, Nicholas S Hellmann

Clin Infect Dis· August 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher CD4+ T cell counts associated with low viral pol replication capacity among treatment-naive adults in early HIV-1 infection.
Jason D Barbour, Frederick M Hecht, Terri Wrin, Mark R Segal, Clarissa A Ramstead, Nicholas S Hellmann

J Infect Dis· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic basis of hypersusceptibility to protease inhibitors and low replicative capacity of human immunodeficiency virus type 1 strains in primary infection.
Andrew J Leigh Brown, Simon D W Frost, Benjamin Good, Eric S Daar, Viviana Simon, Nicholas S Hellmann

J Virol· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleoside and nucleotide analogue reverse transcriptase inhibitors: a clinical review of antiretroviral resistance.
Joel E Gallant, Peter Z Gerondelis, Mark A Wainberg, Nancy S Shulman, Richard H Haubrich, Nicholas S Hellmann

Antivir Ther· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broad nucleoside reverse-transcriptase inhibitor cross-resistance in human immunodeficiency virus type 1 clinical isolates.
Jeannette M Whitcomb, Neil T Parkin, Colombe Chappey, Nicholas S Hellmann, Christos J Petropoulos

J Infect Dis· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prolonged CD4+ cell/virus load discordance during treatment with protease inhibitor-based highly active antiretroviral therapy: immune response and viral control.
Susan A Sufka, Guido Ferrari, Victoria E Gryszowka, Terri Wrin, Susan A Fiscus, Nicholas S Hellmann

J Infect Dis· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population.
Andrew J Leigh Brown, Simon D W Frost, W Christopher Mathews, Keith Dawson, Nicholas S Hellmann

J Infect Dis· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical relevance of non-nucleoside reverse transcriptase inhibitor hypersusceptibility: a prospective cohort analysis.
Richard H Haubrich, Carol A Kemper, Nicholas S Hellmann, Philip H Keiser, Mallory D Witt

AIDS· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypersusceptibility to non-nucleoside reverse transcriptase inhibitors in HIV-1: clinical, phenotypic and genotypic correlates.
Jeannette M Whitcomb, Wei Huang, Kay Limoli, Ellen Paxinos, Terri Wrin, Nicholas S Hellmann

AIDS· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtle decreases in stavudine phenotypic susceptibility predict poor virologic response to stavudine monotherapy in zidovudine-experienced patients.
Nancy S Shulman, Michael D Hughes, Mark A Winters, Robert W Shafer, Andrew R Zolopa, Nicholas S Hellmann

J Acquir Immune Defic Syndr· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic and genotypic HIV-1 drug resistance assays provide complementary information.
Neil Parkin, Colombe Chappey, Laura Maroldo, Michael Bates, Nicholas S Hellmann

J Acquir Immune Defic Syndr· October 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiretroviral-drug resistance among patients recently infected with HIV.
Susan J Little, Sarah Holte, Jean-Pierre Routy, Eric S Daar, Marty Markowitz, Nicholas S Hellmann

N Engl J Med· August 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time trends in primary HIV-1 drug resistance among recently infected persons.
Robert M Grant, Frederick M Hecht, Maria Warmerdam, Lea Liu, Teri Liegler, Nicholas S Hellmann

JAMA· July 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD4+ T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy.
Steven G Deeks, Rebecca Hoh, Robert M Grant, Terri Wrin, Jason D Barbour, Nicholas S Hellmann

J Infect Dis· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis